Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Hung Lin

Showing results (111-120 of 140) with videos related to

Pageof 14
Sort By:
Japanese Journal of Clinical Oncology|January 21, 2010
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatinYu-Yun Shao, Kuan-Ting Kuo, Fu-Chang Hu, et al.
Japanese Journal of Clinical Oncology|January 10, 2018
A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancerTom Wei-Wu Chen, Dah-Cherng Yeh, Tsu-Yi Chao, et al.
Environment International|June 25, 2020
A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese womenMeng-Shan Tsai, Shu-Han Chang, Wen-Hung Kuo, et al.
NPJ Breast Cancer|July 6, 2021
High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East AsiaChing-Hung Lin, Ruby Yun-Ju Huang, Tzu-Pin Lu, et al.
Drug Safety|August 8, 2023
Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary PanelJoanne Wing Yan Chiu, Soo Chin Lee, James Chung-Man Ho, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 10, 2009
Molecular subtypes of breast cancer emerging in young women in Taiwan: evidence for more than just westernization as a reason for the disease in AsiaChing-Hung Lin, Jau-Yu Liau, Yen-Shen Lu, et al.
Journal of Human Genetics|January 27, 2012
Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancerWen-Hong Kuo, Po-Han Lin, Ai-Chu Huang, et al.
Nutrients|September 28, 2023
Lifestyle Factors and Energy Intakes with Risks of Breast Cancer among Pre- and Post- Menopausal Women in TaiwanMeng-Chuan Huang, Tz-Ting Huang, Hsin-Chun Feng, et al.
Breast Cancer Research and Treatment|June 21, 2023
Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancerTom Wei-Wu Chen, Wen Hsiao, Ming-Shen Dai, et al.
Heliyon|February 9, 2023
Deep-learning based breast cancer detection for cross-staining histopathology imagesPei-Wen Huang, Hsu Ouyang, Bang-Yi Hsu, et al.
Pageof 14

Showing results (111-120 of 140) with videos related to

Sort By:
Pageof 14
Japanese Journal of Clinical Oncology|January 21, 2010
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatinYu-Yun Shao, Kuan-Ting Kuo, Fu-Chang Hu, et al.
Japanese Journal of Clinical Oncology|January 10, 2018
A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancerTom Wei-Wu Chen, Dah-Cherng Yeh, Tsu-Yi Chao, et al.
Environment International|June 25, 2020
A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese womenMeng-Shan Tsai, Shu-Han Chang, Wen-Hung Kuo, et al.
NPJ Breast Cancer|July 6, 2021
High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East AsiaChing-Hung Lin, Ruby Yun-Ju Huang, Tzu-Pin Lu, et al.
Drug Safety|August 8, 2023
Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary PanelJoanne Wing Yan Chiu, Soo Chin Lee, James Chung-Man Ho, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 10, 2009
Molecular subtypes of breast cancer emerging in young women in Taiwan: evidence for more than just westernization as a reason for the disease in AsiaChing-Hung Lin, Jau-Yu Liau, Yen-Shen Lu, et al.
Journal of Human Genetics|January 27, 2012
Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancerWen-Hong Kuo, Po-Han Lin, Ai-Chu Huang, et al.
Nutrients|September 28, 2023
Lifestyle Factors and Energy Intakes with Risks of Breast Cancer among Pre- and Post- Menopausal Women in TaiwanMeng-Chuan Huang, Tz-Ting Huang, Hsin-Chun Feng, et al.
Breast Cancer Research and Treatment|June 21, 2023
Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancerTom Wei-Wu Chen, Wen Hsiao, Ming-Shen Dai, et al.
Heliyon|February 9, 2023
Deep-learning based breast cancer detection for cross-staining histopathology imagesPei-Wen Huang, Hsu Ouyang, Bang-Yi Hsu, et al.
Pageof 14